| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the present study, we sought to compare the abilities of NarcotrendTM (NT) with the Bispectral IndexTM (BISTM) electroencephalographic system to monitor depth of consciousness immediately before induction of anesthesia until extubation during a standardized anesthetic. We investigated 26 patients undergoing laminectomy. Investigated states of anesthesia were: awake, loss of response, loss of eyelash reflex, steady-state anesthesia, first reaction, and extubation during emergence. NT, BISTM, spectral edge frequency, median frequency, relative power in , , , ß, and hemodynamics were recorded simultaneously. The ability of all variables to distinguish between awake versus loss of response, awake versus loss of eyelash reflex, awake versus steady-state anesthesia, steady-state anesthesia versus first reaction and extubation were analyzed with the prediction probability. Effects of remifentanil during propofol infusion were investigated with Friedmans and post hoc with Wilcoxons test. Only NT and BISTM were able to distinguish all investigated states accurately with a prediction probability >0.95. After start of remifentanil infusion, only hemodynamics changed statistically significantly (P < 0.05). NT and BISTM are more reliable indicators for the assessment of anesthetic states than classical electroencephalographic variables and hemodynamics, whereas the analgesic potency of depth of anesthesia could not be detected by NT and BISTM. IMPLICATIONS: The modern electroencephalographic monitoring systems NarcotrendTM and Bispectral IndexTM are more reliable indicators for the assessment of anesthetic states than classical electroencephalographic and hemodynamic variables to predict anesthetic conditions from before induction of anesthesia until extubation during a standardized anesthetic regime with propofol and remifentanil. The analgesic potency of depth of anesthesia could not be detected by NarcotrendTM and Bispectral IndexTM.
The measurement of depth of anesthesia is an unsolved problem because there is not yet a clear definition of depth of anesthesia. In recent years, new monitor systems based on the electroencephalogram (EEG) were developed. The usefulness of these monitor systems is hard to quantify because a "gold standard" is not available. A depth-of-anesthesia monitor should separate different clinical end-points (states) of anesthesia, such as awake, loss of response, and first reaction during emergence. Therefore, not only should statistically significant differences be recommended, but values indicating different states should not overlap (1). Smith et al. (2) presented a statistical method, the prediction probability (PK), to detect the accuracy of a variable to distinguish between two or more states of anesthesia. A PK value of 0.5 means that the variable distinguishes between the two states by change (50:50). A PK value of 1.0 indicates a variable distinguishes between the states correctly 100% of the time with no overlap. NarcotrendTM (NT) (MonitorTechnik, Bad Bramstedt, Germany), a new monitor displaying a derived EEG variable, automatically classifies the resting EEG into stages defined by Kugler (3) during the 1980s (4). "Narcotic stages" deescalate from the awake state (stage A) to isoelectric EEG using 14 distinct gradations (3). Adequate depth of anesthesia is indicated by D0, D1, D2, E0, E1, followed by F0 and F1 indicating burst suppression and isoelectric EEG, respectively. Decreasing NT stages during anesthesia were accompanied by decreasing Bispectral IndexTM (BISTM) (Aspect Medical Systems, Newton, MA) values (5). In a very recent study, we were able to demonstrate an advantage of NT over BISTM during emergence with a stepwise reduction of propofol without surgical stimulation (6). No other investigations of the ability of NT to predict anesthetic state during induction have been conducted. Moreover, no information about the effects of added remifentanil infusion on the NT is available. The goal of the present study was to compare NT and BISTM with classical EEG variables and hemodynamics by analyzing the accuracy of each variable to distinguish between different clinically defined states of anesthesia such as awake, loss of response, loss of eyelash reflex, steady-state anesthesia, first reaction, and extubation during emergence. Our hypotheses are that there is no difference in performance between NT and BISTM in differentiation of anesthetic states, and both monitors would be better than classical power spectral EEG or hemodynamics. Moreover, the start of remifentanil infusion during anesthesia with propofol is without an effect on NT and BISTM.
After IRB approval and written informed consent, 26 elective patients were included in the study. Selection criteria were patients aged between 18 and 75 yr, ASA risk classification III, and laminectomy surgery. No patient with any medication interacting with the central nervous or cardiopulmonary system was included in the study to avoid influences on the EEG and the hemodynamics. After premedication with 7.5 mg midazolam per os (30 min before induction), anesthesia was induced with 0.5 µg/mL target controlled infusion (TCI) (Diprifusor, Graseby 3500; Graseby Medical Ltd., Hertfordshire, Watford, UK) of propofol followed by a stepwise increase (0.5 µg/mL) until 3.5 µg/mL propofol was reached. After 5 min, 0.3 µg · kg1 · min1 remifentanil was added. Rocuronium bromide (0.6 mg/kg) was given to facilitate tracheal intubation 10 min after start of remifentanil infusion. Anesthesia was maintained with 3.0 µg/mL propofol and 0.3 µg · kg1 · min1 remifentanil. After the end of surgery, propofol and remifentanil infusions were stopped. Extubation criteria were sufficient spontaneous breathing and spontaneous eye opening. Every minute during induction and emergence, the patients were tested in the same sequence: after test of eyelash reflex the patients were asked to squeeze the observers hand. We defined 6 different anesthetic states: awake, loss of response to squeeze the observers hand, loss of eyelash reflex, steady-state anesthesia with 3.0 µg/mL propofol and 0.3 µg · kg1 · min1 remifentanil, first reaction, and extubation after stopping propofol/remifentanil infusion. Comparisons were performed for awake versus loss of response, awake versus loss of eyelash reflex, awake versus steady-state anesthesia, steady-state anesthesia versus first reaction, and steady-state anesthesia versus extubation.
EEG was registered by seven adhesive silver/silver chloride gel-filled electrocardiograph electrodes (Blue-Sensor; Medicotest, Olstykke, Denmark) on carefully prepared skin (Arbo-Prep; Tyco Healthcare, Neustadt, Germany). Electrode placement was performed according to the instructions of the manufacturers of BISTM (2 channel reference: At1-Fpz and At2-Fpz, ground Fp2) and NT (1 channel bipolar at the hairless skin of the forehead). Electrode impedance was kept below 5 k Heart rate (HR), noninvasive mean arterial blood pressure (MAP), and oxygen saturation were measured and registered at every point of measurement (Solar 8000; Marquette Hellige Medical Systems, Milwaukee, WI). End-expiratory CO2 concentrations were maintained between 3540 mm Hg during the whole observation time. For all variables, the 95%, 90%, 75%, 50%, 25%, 10%, and 5% percentiles were calculated for the investigated states. The accuracy to distinguish between the anesthetic states: awake versus loss of response, awake versus loss of eyelash reflex, awake versus steady-state anesthesia, steady-state anesthesia versus first reaction, and steady-state anesthesia versus extubation were analyzed with the PK. PK was calculated for all variables using the PKMACRO as described by Smith et al. (2). The jackknife method was used to compute the standard error of the estimate (SE). A value of PK = 0.5 means that the variable predicts the states not better than a 50:50 chance. A value of PK = 1.0 means that the variable predicts the states correctly 100% of the time. A value < 0.5 means that discordance is more likely than concordance. To enable comparison of PK, we used 1 PK when the PK value was <0.5 (2). To evaluated the accuracy to distinguish all investigated conditions (PK all) we calculated: PK all = PKawake versus loss of response x PK awake versus loss of eyelash reflex x PK awake versus steady-state anesthesia x PK steady-state anesthesia versus first reaction x PK steady-state anesthesia versus extubation A variable that distinguishes all conditions perfectly with a PK = 1.0 results in PK all = 1.0 x 1.0 x 1.0 x 1.0 x 1.0 = 1.0, a variable which predicts all conditions with PK = 0.5 results in PK all = 0.5 x 0.5 x 0.5 x 0.5 x 0.5 = 0.03125. Changes of all variables after start of remifentanil infusion were tested with the Friedman test for repeated measurements. In case of significant "overall" effects, changes were evaluated in detail a posteriori by Wilcoxons test. Bonferronis correction was performed to account for multiple testing. Statistical analyses were performed using the SPSS version 9 package (SPSS, Chicago, IL) and PKMACRO (2).
Data evaluation was performed in 26 patients (6 women, 20 men, aged 48 ± 10 [SD] yr, weight 83 ± 16 [SD] kg, height 177 ± 9 [SD] cm; Table 1) with almost-artifact-free signal registration. Length of surgery was 93 ± 37 (SD) (Table 1) min without unusual perturbations, such as blood loss or hypothermia. Patients were extubated tracheally at a propofol TCI of 1.3 ± 0.2 (SD) µg/mL without any complications.
The start of propofol and remifentanil infusion resulted in decreases in NT and BISTM (Fig. 1). Changes of all investigated variables during the investigated states are shown in Figure 2. Only NT and BISTM were able to distinguish all investigated states accurately with a PK > 0.95 (Table 2 and Fig. 3) resulting in PK all = 0.97 for BISTM and PK all = 0.96 for NT (Fig. 3).
During 3.5 µg/mL TCI of propofol, resulting in BISTM values of 39 ± 5 (SD) and NT stages of D1, remifentanil infusion of 0.3 µg · kg1 · min1 resulted in no statistically significant effects in all EEG variables during the observation period of 10 min. MAP and HR decreased statistically significantly in the second (HR) or third (MAP) minute after start of infusion (P < 0.05, Fig. 4).
In the present study, we demonstrated the advantage of modern over classical EEG variables and hemodynamics to monitor anesthetic depth. Moreover, the results emphasize the limitation of NT and BISTM to reflect the analgesic power of propofol/remifentanil anesthesia. The measurement of depth of anesthesia is still an unsolved problem because there is no definition of what "depth of anesthesia" means exactly. However, a depth-of-anesthesia monitor would be of enormous clinical interest to increase patient safety and to reduce costs by avoiding drug overdosing. At present, there is no "gold standard" for the measurement of depth of anesthesia. The present study was performed using a propofol and remifentanil regime often used in our hospital. We defined six states from awake through extubation. Steady-state anesthesia was a drug-dosing, regime-dependent state, and it is well known that sensitivity to anesthetics is associated with interindividual variations (7). By determining loss of response, loss of eyelash reflex, first reaction, and the state extubation, we also investigated individual anesthetic states. Data for NT in the literature are rare (5,6,810). In a very recent study, we could demonstrate the possibility of NT to distinguish different states during maintenance and emergence of propofol/remifentanil anesthesia, accurately. However, there is no other investigation evaluating the ability of the NT system to predict anesthetic states during induction of anesthesia. In the present study, NT was able to distinguish all states of anesthesia investigated from induction through extubation accurately. The BISTM is the most evaluated variable derived from the spontaneous EEG, but its status as a depth-of-anesthesia monitor is still controversial (1). In a very recent study, we emphasized the potency of BISTM to distinguish between patients who were awake and those who were anesthetized with propofol and remifentanil. For the 25 investigated patients, no overlap in the data was found between the awake and anesthetized state (9). During emergence, BISTM was not able to distinguish the first reaction during conditions without any external stimulation from the anesthetized state. We hypothesized that this was attributed to the well known 60-second delay of BISTM. Interestingly, in the present study, BISTM was able to distinguish between all investigated conditions, including steady-state anesthesia versus first reaction, accurately. The reason for the better differentiation in the present study may be attributed to stimuli during the emergence period (repetitive commands to squeeze the observers hand). The method used in the present study to record all variables every minute is limited by the delay of the investigated variables. Further studies should be designed to clarify this issue. However, we were not able to use the newest version of BIS (version 3.3 instead of version 4.0) in the present study which may have restricted our results. We used the Aspect A-1000 monitor because it allowed for the possibility of calculating the classical EEG variables.
The present study confirms the limitations of EEG variables to represent the analgesic potency of remifentanil during propofol infusion. These findings are in accordance with the study of Guignard et al. (11) who demonstrated unchanged BISTM values during TCI propofol of 4.0 µg/mL combined with 0, 2, 4, 8, and 16 ng/mL remifentanil plasma concentrations. However, quantitative BISTM responses to noxious stimuli (laryngoscopy and intubation) were attenuated in relation to increasing remifentanil applications. These findings indicate that BISTM is not a reliable indicator for quantitatively predicting responses to painful events, even when BISTM changes are related to analgesic components. To explain the unsatisfying indication of the analgesic power by the BISTM, Guignard et al. (11) hypothesized that these components are mediated in subcortical brain structures and at the level of the spinal cord that cannot be detected by EEG registration from the surface of the scalp. In a recent study (9), we demonstrated that the BISTM and NT were unaffected by decreasing remifentanil concentrations during 3.0 µg/mL TCI of propofol, whereas classical EEG variables have shown statistically significant effects. In the present study, we investigated increasing concentrations of remifentanil during 3.0 µg/mL TCI of propofol. Also, increases in % In the present study, we used the PKMACRO to estimate the PK and SE based on the given data of the 26 patients. It should be mentioned that these estimates are not the true values of PK and SE, but the estimates can be used for statistical hypothesis testing (2). For example, the estimates of PK = 1.0 for awake versus steady-state anesthesia in the present study for BISTM and NT may very well be estimates of PK < 1.0 when more patients are investigated. Both NT and BISTM seemed to be reliable monitor systems to reflect the status of a propofol/remifentanil anesthesia, but NT and BISTM seemed not to be reliable depth-of-anesthesia monitors, because the analgesic power of anesthesia was not reflected.
This article has been cited by other articles:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|